Continuing Education for Respiratory Therapists and Nurses

This program has been approved for 1.0 contact hours Continuing Respiratory Care Education (CRCE) credit by
the American Association of Respiratory Care, 9425 N. MacArthur Blvd. Suite 100, Irving, TX 75063.

This education activity is approved for 1.0 contact hour. Provider approved by California Board of Nursing, Provider # 14477  and the Florida Board of Nursing Provider # 50-17032


Non-Invasive Ventilation and High Flow Oxygenation: How to choose, when and where!


Non-invasive ventilation (NIV) has been shown to be an effective treatment for acute respiratory failure, particularly in chronic obstructive pulmonary disease. High flow nasal cannula (HFNC) therapy has also emerged as a safe, useful therapy in patients with respiratory failure, improving oxygenation and comfort. This CE webinar will focus on the differences in the clinical application of NIV and HFNC with regards to hypercarbic and hypoxic respiratory failure.


David Grooms, MHSH, RRT

Respiratory Clinical Program Manager

Sentara Norfolk General Hospital

Norfolk, VA


Date and Times:

Wednesday, October 5, 2016

12:00 PM EDT/11 AM CDT/9 AM PDT



Saxe Communications and Philips Healthcare
proudly support RT's

Our Speaker:


David Grooms, MHS, RRT is Respiratory Clinical program Manager at Sentra Norfolk, Leigh and Bayside Hospitals in Norfolk, VA. He oversees respiratory care clinical activities for 3 hospitals as well as being responsible for the coordination of staff orientation, research projects, operational duties of multi-specialty ICU. Additionally, Mr. Grooms has published and presented at the state and national level on various respiratory care topics and has been an speaker at several local, sate and national conferences.


Learning Objectives:

Upon completion of this activity, the learner will be able to:

  1. Describe the clinical differences between hypercarbic and hypoxic respiratory failure
  2. Describe the therapeutic differences between NIV and HFNC techniques
  3. Discuss the appropriate selection process for device implementation in association with the disease process

Supported by an educational grant from Philips Healthcare